Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹353.69 Cr
Profit after tax
₹20.92 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations353.69+761.19%1,382.06
Other income14.59+27.09%66.26
Total income368.28+600.82%1,448.32
Employee benefit expense70.64+645.15%213.75
Finance costs1.44+33.33%16.21
Depreciation & amortisation32.41+1,290.99%124.15
Total expenses340.39+631.71%1,287.89
Profit before tax27.89+483.47%116.22
Tax expense6.97+394.33%40.35
Profit after tax20.92+520.77%75.87
Total comprehensive income20.65+512.76%74.89
Earnings per share
Earnings per share, basic₹0.48₹1.75
Earnings per share, diluted₹0.47₹1.72

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Viyash Scientific reported Q4 FY26 revenue of Rs 920 crore, up 19.1% year-on-year, with EBITDA margin expanding to 21.7% and PAT turning around to Rs 66 crore from a loss a year earlier. For the full year, revenue grew 13.8% to Rs 3,420 crore, EBITDA rose 59.6% to Rs 702 crore, and PAT increased more than 14x to Rs 225 crore. Management attributed the improvement to the integration of the merged entity, product mix optimization toward formulations and complex APIs, and merger synergies tracking ahead of initial expectations.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 53 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 16 Aug 2026.